KCM
CELG

Kornitzer Capital Management’s Celgene Corp CELG Stock Holding History

Kornitzer Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,478
Closed -$634K – 485
2015
Q2 		$634K Hold
5,478
– – 0.01% 382
2015
Q1 		$632K Buy
+5,478
New +$655K 0.01% 374

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kornitzer Capital Management's CELG Position: Q3 2015 in Review

Kornitzer Capital Management sold out of Celgene Corp (CELG) in Q3 2015, closing a stake of 5,478 shares — an estimated $634K sold.

Kornitzer Capital Management first reported a position in CELG in Q1 2015 and held it in 2 quarters. The position peaked at $634K in Q2 2015. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

  • Kornitzer Capital Management reported no remaining Celgene Corp position as of Q3 2015 after selling out during the quarter.
  • Kornitzer Capital Management sold 5,478 Celgene Corp shares in Q3 2015, an estimated $634K.
  • Kornitzer Capital Management first reported a position in Celgene Corp in Q1 2015 and held it in 2 quarters.
  • Kornitzer Capital Management's Celgene Corp position peaked at $634K in Q2 2015.
  • 1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Kornitzer Capital Management's 13F filing for Q3 2015, filed 29 Oct 2015.